Quality of Life Assessment in Patients with Androgenetic Alopecia
- PMID: 31523105
- PMCID: PMC6706984
- DOI: 10.4103/ijt.ijt_6_19
Quality of Life Assessment in Patients with Androgenetic Alopecia
Abstract
Background: Male-pattern alopecia (MPA) or androgenetic alopecia (AGA) is a commonly encountered dermatological condition present in males and is less common among females. Although AGA is a physiological condition, its impact on person's self-esteem is so great that it cannot be ignored. It has a significant affect over a variety of physiological and social aspects of one's life and even on the individual's overall quality of life (QOL).
Aims and objectives: The aim of this study is to study the clinical profile of 200 male patients having MPA and to access its impact on QOL using the Dermatology Life Quality Index (DLQI) and hair-specific Skindex-29.
Materials and methods: Clinical profiles of 200 patients were studied, and QOL assessment was done using the DLQI and hair-specific Skindex-29 scales.
Results: Of 200 cases of MPA, majority (41.5%) of the patients belonged to the age group of 21-30 years. Smoking, alcoholism, dietary habits, nature of work, and seasonal variation did not seem to affect the incidence of MPA. Positive family history of MPA was observed in 50% of patients. A mean DLQI score of 13.52 was recorded in the study. The main affected parameter was personal relations with mean score of 2.3. Maximum number of patients had DLQI score between 11 and 20. MPA was observed in 50% of patients. In the study, the mean hair-specific Skindex-29 score was found to be 75.62. The different subscale parameters in Skindex-29 were symptoms, functions, emotions; with respective score of 22.1 ± 5.025, 25.89 ± 4.814, and 27.73 ± 5.942. The major subscales affected were symptoms with a mean score of 3.14. Both hair-specific Skindex-29 and DLQI had a significant correlation, thereby suggesting that AGA significantly affects patient's QOL.
Conclusion: AGA harmfully affected the patient's QOL which warns the physicians to pay more attention to QOL impairment in patients of AGA for the better understanding of the disease burden on individual patients.
Keywords: Androgenetic alopecia; India; male; observational study.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People's Republic of China.Patient Prefer Adherence. 2017 Jan 27;11:151-155. doi: 10.2147/PPA.S121218. eCollection 2017. Patient Prefer Adherence. 2017. PMID: 28203058 Free PMC article.
-
Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study.Ann Dermatol. 2012 Aug;24(3):311-8. doi: 10.5021/ad.2012.24.3.311. Epub 2012 Jul 25. Ann Dermatol. 2012. PMID: 22879715 Free PMC article.
-
Cross sectional quality of life assessment in patients with androgenetic alopecia.Dermatol Ther. 2020 Jul;33(4):e13799. doi: 10.1111/dth.13799. Epub 2020 Jul 9. Dermatol Ther. 2020. PMID: 32520416
-
Health-Related Quality of Life, Depression, and Self-esteem in Patients With Androgenetic Alopecia: A Systematic Review and Meta-analysis.JAMA Dermatol. 2021 Aug 1;157(8):963-970. doi: 10.1001/jamadermatol.2021.2196. JAMA Dermatol. 2021. PMID: 34232264 Free PMC article.
-
Androgenetic alopecia: an evidence-based treatment update.Am J Clin Dermatol. 2014 Jul;15(3):217-30. doi: 10.1007/s40257-014-0077-5. Am J Clin Dermatol. 2014. PMID: 24848508 Review.
Cited by
-
Exploiting Recent Trends in the Treatment of Androgenic Alopecia through Topical Nanocarriers of Minoxidil.AAPS PharmSciTech. 2022 Nov 1;23(8):292. doi: 10.1208/s12249-022-02444-0. AAPS PharmSciTech. 2022. PMID: 36319878 Review.
-
Positioning of Low Alcohol or Alcohol-Free Minoxidil Formulation for the Management of Androgenetic Alopecia: Indian Perspective.Int J Trichology. 2023 Jan-Feb;15(1):13-17. doi: 10.4103/ijt.ijt_54_22. Epub 2023 Apr 19. Int J Trichology. 2023. PMID: 37305189 Free PMC article. Review.
-
Measuring Patient Quality of Life Following Treatment for Alopecia.Patient Prefer Adherence. 2021 Jul 16;15:1601-1610. doi: 10.2147/PPA.S282399. eCollection 2021. Patient Prefer Adherence. 2021. PMID: 34295154 Free PMC article. Review.
-
Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study.Sci Rep. 2023 Mar 31;13(1):5308. doi: 10.1038/s41598-023-32356-3. Sci Rep. 2023. PMID: 37002313 Free PMC article.
-
Psychology's medicalization of male baldness.J Health Psychol. 2022 Aug;27(9):2161-2180. doi: 10.1177/13591053211024724. Epub 2021 Jun 22. J Health Psychol. 2022. PMID: 34154437 Free PMC article. Review.
References
-
- Price VH. Androgenetic alopecia in women. J Investig Dermatol Symp Proc. 2003;8:24–7. - PubMed
-
- Passchier J. Quality of life issues in male pattern hair loss. Dermatology. 1998;197:217–8. - PubMed
-
- Terry RL, Davis JS. Components of facial attractiveness. Percept Mot Skills. 1976;42:918. - PubMed
-
- Cash TF. The psychology of physical appearance: Aesthetics, attributes and images. In: Cash TF, Pruzinsky T, editors. Body Images: Development, Deviance and Change. New York, Guilford: 1990. pp. 51–79.
-
- Girman CJ, Rhodes T, Lilly FR, Guo SS, Siervogel RM, Patrick DL, et al. Effects of self-perceived hair loss in a community sample of men. Dermatology. 1998;197:223–9. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous